NCT03338881 2023-02-08A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma MalignanciesCalithera Biosciences, IncPhase 1 Withdrawn